Optimized antibodies that target CD19

Details for Australian Patent Application No. 2007285976 (hide)

Owner Xencor, Inc

Inventors Lazar, Gregory Alan; Chu, Seung Yup; Pong, Erik WeiKing; Zhukovsky, Eugene Alexander; Bernett, Matthew J.; Karki, Sher Bahadur; Richards, John O.; Desjarlais, John R.

Agent Davies Collison Cave

Pub. Number AU-B-2007285976

PCT Pub. Number WO2008/022152

Priority 60/822,362 14.08.06 US

Filing date 14 August 2007

Wipo publication date 21 February 2008

Acceptance publication date 18 August 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/022152 Priority application(s): WO2008/022152

18 August 2011 Application Accepted

  Published as AU-B-2007285976

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286000-Tolerance ring having variable height and/or assymmetrically located bumps

2007285965-A fluid loss control system and method for controlling fluid loss